In the present review, we discuss the role of indoleamine 2,3-dioxygenase (IDO1), a tryptophan metabolizing enzyme with immunoregulatory function [17], as a factor modulating the activity of the innate immune system in the course of IRI-induced AKI. Here, IDO1 is linked to acute kidney injury.